Netributor.com

Stephanie Faris

Stephanie Faris

Stephanie is a freelance writer and novelist whose work has appeared on NYPost.com, PSMag.com, the Intuit Small Business Blog, and many others. She is the Simon & Schuster author of 8 children's books, including the Piper Morgan chapter book series, 25 Roses, and 30 Days of No Gossip.

Scientists have been experimenting with ways to feed humans in space. But that same technology could be put to use on Earth, where food shortages are already a real problem across the globe. NASA has taken up the challenge, using technology to speed breed six generations of crops each year.

The work is being done at the John Innes Centre, where scientists are going well beyond the annual production rate of two generations of crops. By being able to triple crop production, scientists believe they’ll able to fast-track developments like greater resistance to disease and global warming. They’ll also be able to produce a higher volume of crops to help reduce the food insecurities in various areas.

It’s only a matter of time before technology is able to restore vision to those who are completely blind. But some improvement is coming sooner than you think, thanks to Bionic Vision Technologies. During a trial, four Australian patients who had suffered significant vision loss due to degenerative Retinitis Pigmentosa saw notable improvement.

Prior to the trial, the four participants could sense light and dark, but they were unable to even detect a hand moving in front of them. Researchers implanted bionic eyes and the patients could detect objects around them in grayscale, which meant they could navigate without the use of guide dogs or a walking stick.

Organ transplant recipients spend the days following their operations worrying that their bodies will reject the new organ. But a new type of immunotherapy created by a team at Mount Sanai could reduce that risk. The therapy relies on nanotechnology, which can target the cells that initiate the immune response that leads to the organ rejection.

The rejection happens when the myeloid cells activate T-cells that attack the new organ. The medical community is already aware of this process, which is why organ transplants now take drugs that suppress that immune response. Unfortunately, those drugs can put patients at risk for infection and cancer.

Page 1 of 160
Home Stephanie Faris

Newsletter Signup

Live support

Available Monday - Friday, 9 AM - 5 PM EST

Connect with us

Netributor Main Offices

1

Canada

Email: accounts@netributor.com
2

Singapore

Email: accounts@netributor.com